Vivo Capital — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
ABK Biomedical is a clinical-stage medical device company that develops x-ray visible glass microspheres for Y-90 radioembolization and embolic treatment of cancers such as liver cancer.
BiotechHealthtechMedical DevicesHalifax, CA
Bob Abraham(Executive Officer, Director)Robert Abraham(Co-founder (Interventional Radiologist, MD))Daniel Boyd(Co-founder (Material Scientist))Sharon Kehoe(Co-founder (Material Scientist))Anthony Headley(Executive Officer)Gary Donofrio(Executive Officer)
Board seatJoseph Siletto· per SEC Form D · $2.6M raise · filed Nov 2025
Co-investorsEight Roads VenturesF-Prime Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.